- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02134145
Scanadu Consumer Health Outcomes (SCOUT) Study (SCOUT)
Usability Study of the Scanadu Scout
There is a great need within healthcare to develop systems of care that better engage and activate people in their own care before they become patients. By so doing lay users will be empowered to take charge of their own care in recognizing they can change their health and improve their quality of life. Mobile health technologies such as the Scanadu ScoutTM hold the potential to truly engage individuals in the way needed through real-time data capture, transmission and connectivity.
We propose to evaluate the real-world use of the Scanadu ScoutTM by a cohort of self-selected investors in an earlier crowdfunding campaign on Indiegogo for the Scanadu Scout™, through a prospective observational study. Using validated survey tools and through the remote tracking of frequency of use and physiological measurements from the Scanadu Scout™ device and app.
Participants will receive web-based surveys at 4 time points: baseline, 3, 12 and 18 months.
Participants will be instructed to use the Scanadu Scout™ as much as they would like. The parameters that will be functional on the device and available for measurement by the participant are:
- Heart rate
- Respiratory rate
- Temperature
- Oxygen saturation
- Heart rate variability
- Blood pressure
Data analysis will examine individual participant and aggregate level:
- Usage and physiologic measurement data of the device,
- Perceptions of the device, and
- Changes in self-reported health self-management, health-related quality of life, participant- physician communication and medication adherence between baseline and follow-up.
Studieoversikt
Status
Forhold
Detaljert beskrivelse
We propose to evaluate the real-world use of the Scanadu ScoutTM by a cohort of self-selected investors in an earlier crowdfunding campaign on Indiegogo for the Scanadu Scout™, through a prospective observational study. Using validated survey tools and through the remote tracking of frequency of use and physiological measurements from the Scanadu Scout™ device and app, this study will provide preliminary evidence for:
- Level of engagement and impact of Scanadu ScoutTM on health behavior with a focus on potential risks and safety.
- Long term (up to 18 months) recurrent usage rate of the various physiologic measurements linked to users and survey data.
- Ease of use and acceptance of the Scanadu ScoutTM technology.
This study will utilize a longitudinal cohort design. All Scanadu Scout investors (~5000 individuals) will be invited to participate in the study prior to receiving their Scanadu Scout™. Potential participants will receive a link to an online study platform. The platform will contain the Informed Consent form and all the study materials. After a participant reads and signs the Consent the participant will be enrolled in the study and a Scanadu Scout™ device will be sent. The participant will download the Scanadu Scout™ app from the App Stores (iOS/Android). The app will require a handshake with a Scanadu Scout™ device before it becomes fully functional to limit access to study participants.
After signing the Informed Consent form the participant will be asked to complete baseline surveys to assess participant characteristics, health self-management and health-related quality of life prior to using the Scanadu Scout™. At 3 months, 12 months, and at 18 months, a participant will be asked to complete Health Self-Management and Health-Related QOL surveys as well as an additional assessment of their perceptions of the device. Backers who do not wish to partake in this study will not receive the device and will be entitled to get their contribution back.
Participants will be instructed to use the device as much as they would like over the course of the study. The parameters that will be functional on the device and available for measurement by the participant are:
- Heart rate
- Respiratory rate
- Temperature
- Oxygen saturation
- Heart rate variability
- Blood pressure
Data analysis will examine individual participant and aggregate level:
- Usage and physiologic measurement data of the device,
- Perceptions of the device, and
- Changes in self-reported health self-management, health-related quality of life, participant- physician communication and medication adherence between baseline and follow-up.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
California
-
La Jolla, California, Forente stater, 92037
- Scripps Translational Science Institute
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Over 18 years of age
- Signed Informed Consent Form
Exclusion Criteria:
- None
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
---|
Self Selected Investors
A self selected crowdfunding backers from teh Scanadu Scout Crowdfunding campaign.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Participant Characteristics
Tidsramme: Baseline
|
|
Baseline
|
Changes in psychological outcomes as measured by:
Tidsramme: Baseline, 3 months, 12 months, and 18 months
|
a. Anxiety Levels (Speilberger State-Trait Anxiety Inventory; STAI Y-6 item)
|
Baseline, 3 months, 12 months, and 18 months
|
Changes in Health Outcomes as measured by:
Tidsramme: Baseline, 3 months, 12 months, and 18 months
|
|
Baseline, 3 months, 12 months, and 18 months
|
Changes in Lifestyle Outcomes as measured by:
Tidsramme: 3 months, 12 months, and 18 months
|
|
3 months, 12 months, and 18 months
|
Perceptions of the Scanadu Scout™ as measured by
Tidsramme: 3 months, 12 months, and 18 months
|
|
3 months, 12 months, and 18 months
|
Samarbeidspartnere og etterforskere
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Steven Steinhubl, MD, STSI
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- Scanadu
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .